3i-o Prescribing Project Work Package 2 v0.4
Research type
Research Study
Full title
Impact of an Intervention on Inequalities in Overprescribing - the 3i-o study WP 2
IRAS ID
344331
Contact name
Sarah Alderson
Contact email
Sponsor organisation
University of Leeds
Duration of Study in the UK
1 years, 1 months, 31 days
Research summary
Overprescribing is getting medicines that the patient may not want, may not need or may cause more harm than good. Overprescribing increases the medication burden for patients and risks adverse effects, hospital admissions and deaths. It wastes medications and increases costs to the NHS.
Our previous research has shown that providing performance feedback to GP Practices often works in reducing overprescribing. However, we do not know if it works effectively for all patients. We don't know if it makes health inequalities better or worse. We want to find out if providing feedback interventions or similar interventions to reduce overprescription of addictive painkillers and antibiotics work without making it more difficult for some people to get the health care and support they need. We want to understand what clinicians and patients think is the right balance between reducing overprescribing overall and reducing inequalities in overprescribing.
The aim of this study is to interview prescribing clinicians and patients about overprescribing of addictive painkillers and antibiotics and its impact on inequalities.REC name
London - Stanmore Research Ethics Committee
REC reference
24/PR/1309
Date of REC Opinion
26 Nov 2024
REC opinion
Further Information Favourable Opinion